Microcurrent Device Market Size, Share, Industry Forecast by 2032 (2025)

Microcurrent Device Market Size

The global microcurrent device market is expected to register a rapid revenue CAGR of 7% during the forecast period. Rising demand for non-invasive cosmetic procedures is a key factor driving market revenue growth. Microcurrent technology is a noninvasive therapy that sends out a low-voltage current that is similar to natural electrical currents in the body. Weak electrical signals are used to stimulate the muscles and skin during a microcurrent facial. According to a research, microcurrent stimulation has various advantages, including enhancing muscular function, facilitating wound healing, and lowering inflammation. Microcurrent facials do not require anesthesia or incisions like other more invasive procedures do. One of the most recent inventions to generate a discussion is the microcurrent facial, in which electricity is used in this beauty procedure to encourage skin cell proliferation. The mircocurrent treatment is painless, non-invasive, and requires no injections. As microcurrent facials are gentle and non-invasive, making these ideal for individuals with sensitive skin as well as individuals with all skin types and tones.

Microcurrent Device Market Drivers

In addition, increasing awareness about benefits of microcurrent facial treatments is another key factor driving revenue growth of the market. It is advised to receive a minimum of five microcurrent face treatments, while noticeable benefits can and will be shown after only one treatment and ideally, these are staggered twice weekly and are followed by monthly maintenance sessions. Long-term advantages of microcurrent facials include improved elasticity brought on by a rise in natural elastin production, improved collagen creation and skin cell turnover, and decreased wrinkles and fine lines and pigmentation and roughness of skin. Moreover, microcurrent facials are the best skin care treatment all year round as these are quick, painless, and completely adjustable, however, if one wants to target persistent melasma or post-summer pigmentation, these are especially effective in the autumn.

A recent trend in the market is increasing use of Frequency-Specific Microcurrent (FSM), in which low electrical current levels are used to reduce discomfort. This form of treatment can be applied to particular body tissues to relieve pain brought on by illnesses or accidents, but typically, there is no pain. The pace at which a sound wave or electronic pulse is generated is known as its frequency, while the unit of measurement is Hertz (Hz). Different frequencies can be applied during FSM therapy in an effort to perhaps lessen swelling (inflammation), repair tissue, and lessen pain.

In addition, FSM is most frequently used to treat pain from illnesses such as shingles, burns, kidney stones, asthma, irritable bowel syndrome, disc injuries, fibromyalgia, diabetes-related neuropathy, and pain from muscles and nerves. These also include inflammation and scar tissue, tendinopathy (inflammation and/or swelling of the tendon), neuromas (overgrowth and scarring to a nerve following an injury), chronic (long-term) and acute (sudden) musculoskeletal injuries, both short-term and long-term neuropathic pain, chronic bone and fracture pain, disc injuries/discogenic and facet-based discomfort, torticollis (tilting of the head to one side), arthritis discomfort referred from within, sports injuries, concussions, headaches, plantar fasciitis (foot and heel pain), and wounds.

Microcurrent Device Market Restraints

However, high cost of microcurrent facials is a key factor , which could restrain market revenue growth. Usually, those who want a microcurrent facial for aesthetic reasons are responsible for covering the cost of procedure. A medical problem, such as a cut or severe acne, can, nevertheless, make it possible to obtain insurance that will pay for the surgery. The price varies according to the patient's location and provider they choose. The majority of clinics charge USD 200 to USD 600 per session. In addition, the price of at-home devices, which an individual can use again, can range from USD 180 to USD 500, depending on the size, power, and presence of any auxiliary attachments.

Microcurrent Device Market Segment Insights

Type Insights:

Based on type, the global microcurrent device market is segmented into pull type and wheel type. The pull type segment is expected to account for largest revenue share in the global microcurrent device market over the forecast period owing to increasing product launch activities by key market players. For instance, FOREO with BEAR, transformed the application of microcurrent to anti-aging skincare three years ago. In the present, the company introduced BEAR 2, most potent microcurrent device in the world, which provides long-lasting anti-ageing results without discomfort, problems, or recovery time associated with intrusive cosmetic procedures. Clinical testing has shown that BEAR 2 considerably improves deep wrinkles, fine lines, skin firmness and elasticity in just one week of use, making it a safe, painless, and non-invasive alternative to facelift and botox.

Application Insights:

On the basis of application, the global microcurrent device market has been segmented into home and commercial. The commercial segment is expected to register steadily fast revenue growth rate in the global microcurrent device market over the forecast period. This is owing to several individuals adopting microcurrent devices for commercial applications, which is leading to increasing product launch activities by key market players to meet this demand. For instance, NuFACE, a leader in clinically-proven, top-selling microcurrent skincare since 2005, announced the availability of Mini+ and Trinity+, two of its Food and Drug Administration (FDA)-approved products. The company also made available its ground-breaking Bluetooth-enabled NuFACE App, which makes it simple to connect the devices and unlock advanced treatments that target layers of skin that topical skincare cannot reach.

The home segment is expected to account for significantly large revenue share in the global microcurrent device market during the forecast period owing to increasing adoption of microcurrent devices in homes. At-home microcurrent therapy devices offer improved radiance, better lymphatic drainage, stimulated collagen, and diminished fine lines over time. In addition, certain businesses offer at-home body microcurrent devices. Although, these are not designed for workouts as equipment trainers use, but can be very effective for firming and toning the skin on body.

Microcurrent Device

Regional Insights

The North America market is expected to account for largest revenue share in the global microcurrent device market during the forecast period attributed to increasing product launch activities by key market players in countries in this region. For instance, according to NuFACE, pioneers in award-winning and cutting-edge at-home microcurrent technology, IonPlex Ionized Skincare Activators, a special combination of electrically charged ions and glacial water, deliver a surge of active ingredients for optimal microcurrent results and healthy, younger-looking skin. Both of the brand-new, FDA-approved ionized Microcurrent Activators elevate one’s NuFACE Device routine and lay groundwork for a comprehensive approach to microcurrent skincare. The potent treatments, which come in two distinct formulas, are created to maximize one’s microcurrent results right away by sending the current deep into muscles of the face while also delivering long-term skincare advantages.

The Asia Pacific market is expected to register fastest revenue growth rate in the global microcurrent device market over forecast period attributed to increasing partnership activities in countries of this region. For instance, JinMed announced the creation of Beauty Products Division as a part of its expansion into the production of lifestyle beauty products. The business has successfully created three items in partnership with renowned Japanese beauty product maker MIYAKO: ’facial management equipment,’ ’slimming fat burning equipment,’ and ’health management equipment.’ Currently, Avant Beauty Biotech (Shanghai) Co., Ltd. has placed 600 orders for the product, which amply illustrates the market's awareness of JinMed's Research & Development (R&D) expertise in the product.

The Europe market is expected to account for considerably large revenue share in the global microcurrent device market over the forecast period due to increasing product launch activities by key players in countries of this region. For instance, Healthtech startup NuroKor.com has created a portable device that employs ’quadwave microcurrent‘ technology. The Mi-Touch applies Microcurrent (MCS), Neuromuscular Stimulation (NMS), and Peripheral Nerve Stimulation (PNS) types of bioelectrical pulses through the skin. The tool has a number of sticky pads that adhere to injured area and can be worn throughout the day, while unwinding, or even while one sleeps. This equipment is used on certain settings by athletes and fitness enthusiasts while they workout to build additional strength.

Microcurrent Device Top

Companies and Competitive Landscape

The global microcurrent device market is consolidated, with few large and medium-sized players accounting for the majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective microcurrent device products.

Some major players included in the global microcurrent device market report are:

• ReFa
• NuFACE
• ShowYoung
• ZIIP
• PureLift
• Vanity Planet
• YEAMONS
• TOUCHBeauty
• The Beautools Facepump
• FOREO
• KinGDom
• PowerDot
• FlexxiCore
• Avazzia
• Contour Kinetics
• LightStim
• Newa
• Project E Beauty
• Trophy Skin
• Silk’n

Microcurrent Device Latest Industry Updates

• On 28 February 2023, Bio-Therapeutic Inc. introduced the bt-sculpt, a new handheld facial toning tool, which will provide professional-grade skin lifting and firming by building on the brand's tried-and-true microcurrent technology. The rechargeable device has four surface-optimized self-tensioning probes. The application of microcurrent is simplified by two pre-programmed face routines, and unique Suzuki Sequencing technology delivers real microcurrent over two channels and four energy routes. Through a special internal processor that makes sure the proper current levels are always being delivered to the skin, Suzuki Sequencing optimizes wave forms.

• On 25 March 2021, the ClearUP Sinus Pain Relief handheld device from Tivic Health Systems now has allergy, flu, and common cold congestion included under its enlarged list of indications for usage by the U.S. Food and Drug Administration (FDA). The most recent indication is in addition to FDA approval for the treatment of nasal pain associated to allergens that is brought on by seasonal and year-round allergies. ClearUP offers consumers relief from sinus pain and congestion by employing soft microcurrent waveforms. It uses low current electrical waveforms to stimulate nerves under the skin along with cheek, nose, and brow bone outside the nasal passages to help relieve sinus pain and congestion.

Microcurrent Device Report Summary

Microcurrent Device Market Segmentation Analysis

For the purpose of this report, Emergen Research has segmented the global microcurrent device market on the basis of type, application, and region:

• Type Outlook (Revenue, USD Million; 2019–2032)

  • Pull Type
  • Wheel Type

• Application Outlook (Revenue, USD Million; 2019–2032)

  • Home
  • Commercial

• Regional Outlook (Revenue, USD Million; 2019–2032)

  • North America
    1. U.S.
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. UK
    3. France
    4. Spain
    5. BENELUX
    6. Rest of Europe
  • Asia Pacific
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • Middle East & Africa
    1. Saudi Arabia
    2. UAE
    3. Israel
    4. Rest of Middle East & Africa